These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 33152930)

  • 1. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
    Lin Z; Lu S; Xie X; Yi X; Huang H
    Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer.
    Garajová I; Balsano R; Tommasi C; Giovannetti E
    Curr Pharm Des; 2018; 24(39):4601-4604. PubMed ID: 30659532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
    Lin Z; Xie X; Lu S; Liu T
    Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncoding RNAs and pancreatic cancer.
    Peng JF; Zhuang YY; Huang FT; Zhang SN
    World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer.
    Wei L; Sun J; Wang X; Huang Y; Huang L; Han L; Zheng Y; Xu Y; Zhang N; Yang M
    Front Cell Dev Biol; 2023; 11():1226639. PubMed ID: 37560164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of circular RNAs and autophagy-related miRNAs in the diagnosis and treatment of pancreatic cancer.
    Jiang PC; Bu SR
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):511-516. PubMed ID: 31610988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications.
    Reese M; Dhayat SA
    J Hematol Oncol; 2021 Sep; 14(1):141. PubMed ID: 34496946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
    Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of non-coding RNAs in pancreatic cancer: the bane of the microworld.
    Tang YT; Xu XH; Yang XD; Hao J; Cao H; Zhu W; Zhang SY; Cao JP
    World J Gastroenterol; 2014 Jul; 20(28):9405-17. PubMed ID: 25071335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review.
    Zhao D; Wu T; Tan Z; Xu J; Lu Z
    Expert Rev Anticancer Ther; 2024 May; 24(5):239-251. PubMed ID: 38594965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
    Perakis SO; Thomas JE; Pichler M
    Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
    Wei L; Sun J; Zhang N; Shen Y; Wang T; Li Z; Yang M
    Front Cell Dev Biol; 2021; 9():764313. PubMed ID: 34881242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer.
    Xie W; Chu M; Song G; Zuo Z; Han Z; Chen C; Li Y; Wang ZW
    Semin Cancer Biol; 2022 Aug; 83():303-318. PubMed ID: 33207266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance.
    Yang Z; Ma R; Li J; Zhao L
    Pharmacol Res; 2023 Feb; 188():106678. PubMed ID: 36709789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.